- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01097161
Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program (SAS:EIP)
April 1, 2010 updated by: Federal University of Minas Gerais
The Speech Prosody of People With Stuttering and Developmental Apraxia: the Efficacy of an Intervention Program
Subjects' utterances were submitted to acoustic analysis before and after the intervention program applied on prosodic basis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study has the aim of developing knowledge, methodology and technique in the prosody area, for its application on the speech therapy, with the assistance of a feedback system - with WinpitchPro (Philippe Martin).
A database was constituted on the basis of a patterned corpus (EUROM1) by its translation, recording and editing on .wav
format.
Throughout model-sentences, an experimental intervention program initiates with the participation of 2 adults with stuttering problem and 2 with apraxia of speech.
The efficacy of the therapeutic procedure is tested on the basis of the acoustical and the statistical analyses which have compared the first and the second speech samples taken before and after the twenty (20) therapy sessions held in a prosody approach only.
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brazil, 30150340
- R. Grão Pará, 85/404
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of stuttering
- Clinical diagnosis of apraxia of speech
- 18 years of age or older
- Portuguese native language
- Agreement by the participant to enroll on 20 therapy sessions scheduled in a 3 month period
Exclusion Criteria:
- History of major medical illness unrelated to primary diagnosis of developmental stuttering and developmental apraxia of speech
- Significant abnormalities on general physical and neurological examination unrelated to primary diagnosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Speech treatment on prosodic basis
Patients receive 20 therapy sessions over a course of 3 months, with one double session per week.
|
Two weekly speech sessions realized on individual basis for three months period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2007
Primary Completion (Actual)
October 1, 2007
Study Completion (Actual)
June 1, 2008
Study Registration Dates
First Submitted
March 31, 2010
First Submitted That Met QC Criteria
March 31, 2010
First Posted (Estimate)
April 1, 2010
Study Record Updates
Last Update Posted (Estimate)
April 2, 2010
Last Update Submitted That Met QC Criteria
April 1, 2010
Last Verified
April 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHA 0097/06
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stuttering
-
University of Texas at AustinRecruitingStuttering | Stuttering, Childhood | Stuttering, Adult | Stuttering, DevelopmentalUnited States
-
University of MichiganNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingStuttering | Stuttering, Childhood | Stuttering, AdultUnited States
-
Biruni UniversityRecruitingStuttering, AdultTurkey
-
University of PittsburghUniversity of Michigan; National Institute on Deafness and Other Communication...Recruiting
-
University of MichiganNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingStuttering | Stuttering, ChildhoodUnited States
-
Riphah International UniversityCompletedStuttering, AdultPakistan
-
University of OxfordCompletedStuttering, DevelopmentalUnited Kingdom
-
Iran University of Medical SciencesCompletedStuttering/ DevelopmentalIran, Islamic Republic of
-
Assiut UniversityUnknownStuttering, Childhood
-
The Hong Kong Polytechnic UniversityCompletedStuttering, Adult | StammeringHong Kong
Clinical Trials on speech therapy with the assistance of an acoustical analysis program
-
Association des Paralysees de France (APF)Fondation de FranceRecruitingAdolescent Idiopathic ScoliosisFrance
-
University of Alabama at BirminghamUniversidade Estadual de LondrinaRecruiting
-
Basque Health ServiceCarlos III Health Institute; Preventive Services and Health Promotion Research... and other collaboratorsUnknown
-
Satellite HealthcareRecruiting
-
I.M. Sechenov First Moscow State Medical UniversityEnrolling by invitationCOVID-19 | Quality of Life | Oxygen Consumption | Diastolic Dysfunction | Endothelial Function | Exercise ToleranceRussian Federation
-
BonusBio Group LtdCompletedBone Void in the Maxillofacial AreaIsrael
-
Umm Al-Qura UniversityRecruitingPHYSICAL THERAPY TECHNIQUESSaudi Arabia
-
Luxembourg Institute of HealthLuxembourg Centre for Systems Biomedicine; FNR (Luxembourg National Research... and other collaboratorsNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingHead and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage... and other conditionsUnited States, Canada